Intended for healthcare professionals

Editorials

Pre-eclampsia and the risk of cancer

BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7445.909 (Published 15 April 2004) Cite this as: BMJ 2004;328:909
  1. Aliki Taylor, Cancer Research UK training fellow in cancer public health and epidemiology (A.J.Taylor@bham.ac.uk)
  1. Department of Public Health and Epidemiology, University of Birmingham, Birmingham B15 2TT

    Several studies suggest a decreased risk—except this one

    This issue of the BMJ includes a study which examines the relation between pre-eclampsia and cancer.1 Many researchers have suggested that pre-eclampsia or hypertension in pregnancy is associated with a reduced risk or no excess risk of cancer in the mother.28 However this week's study by Paltiel et al shows an increased risk of cancer after pre-eclampsia.1

    Despite decades of research, there is still confusion over the cause of pre-eclampsia. It is relatively common, affecting 3-5% of pregnancies, and is a leading cause of morbidity and mortality both in the mother and unborn child.9 Several observational studies in European and North American populations have examined the relation between pre-eclampsia (or hypertension) in pregnancy and cancer.28 Unfortunately some were based on a small number of cancers in the pre-eclampsia group, not all adjusted for known confounders, and the length of follow up varied. Most of these studies found a …

    View Full Text

    Log in

    Log in through your institution

    Subscribe

    * For online subscription